Navigation Links
Bioheart, Inc. Announces Financial Results for Second Quarter 2008
Date:7/30/2008

Report on Form 10-K for the year ended December 31, 2007, as amended by Amendment No. 1 on Form 10-K/A and its quarterly report on Form 10-Q for the quarter ended March 31, 2008.

Financial Tables on Following Pages

Bioheart, Inc. and Subsidiaries

Consolidated Balance Sheets

June 30, December 31,

2008 2007

(Unaudited) (Derived from

audited

financial

statements)

ASSETS

Current assets

Cash and cash equivalents $1,879,995 $5,492,157

Receivables 53,870 52,642

Inventory 375,832 372,054

Prepaid expenses and other current assets 2,328,441 261,030

Total current assets 4,638,138 6,177,883

Property and equipment, net 370,517 444,506

Deferred offering costs - 3,484,070

Deferred loan costs, net 662,928 1,146,716

Other assets 68,854 71,148

Total assets $5,740,437 $11,324,323

LIABILITIES AND SHAREHOLDERS' DEFICIT

Current liabilities

Accounts payable $1,878,359 $2,134,256

Accrued expenses 4,436,731 4,511,775

Deferred revenue
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bioheart, Inc. to Report Full Year 2007 Financial Results on Thursday, March 27, 2008
2. Bioheart, Inc. Announces Financial Results for First Quarter 2008
3. Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
4. Bioheart, Inc. to Host Annual Meeting of Shareholders on Wednesday, July 30, 2008
5. Bioheart, Inc. to Transfer to Nasdaq Capital Market
6. Bioheart, Inc., Added to Russell Microcap Index
7. Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
8. Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
9. Bioheart, Inc., Announces Management Change
10. Bioheart, Inc. Announces Results of Annual Meeting
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNews...ed today it is acquiring the assets of Hyland Seed...tario. The addition of Hyland Seeds will further e...the company anticipates the introduction of Smart...de Tolerant Trait Technology in corn in 2012. The ...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November ... (Nasdaq: DCGN ) today announced the approval of a...cy Court for the District of Delaware,(the "Bankru...etition for,relief under Chapter 11 of the United ..., The orders issued by the Bankruptcy Cou...
(Date:11/24/2009)...SEATTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.a...opmentAuthority(OPDA)wererecentlyawarded$2millionb...oard(CERB)inaprivate/publicpartnershiptoconstructt...colnCounty,WA. ,, "Thisinvestmentwillsignifican...70greenjobstoLincolnCounty,"saidBlueMarbleEnergyCE...
(Date:11/24/2009)..., DUBLIN, November 24 /PRNewswire-FirstCall...obal specialty biopharmaceutical company, today,an...n Medicines Agency for,velaglucerase alfa, the com...or the treatment of Type 1 Gaucher disease. This i...e alfa that has been submitted, with previous,subm...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
...edic Imaging, PARIS and ATLANTA, Oct. 9 Biospace...arance from the Food and Drug Administration,(FDA)...nited States for 2D,imaging use. EOS 2D|3D techno...ging,allowing images to be obtained with a low dos...al imaging, permitting full-body, uninterrupted di...
...echnology company translating the complexity of hu..., today announced that Andrea Matthews,(age 25), m... Mass High,Tech for its "People to Watch Under 30....idual like Andrea as,part of our team," said Dr. K..."She has been a go-getter ever since she started a...
...ey, OAK BROOK, Ill. and CARY, N.C., Oct. 9 The U...ce of academic medical centers and,their affiliate...ent,technology and services for academic and resea...rship to provide organizations participating in,UH...a robust, easy-to-use,procurement engine to stream...
Other Biology Technology:FDA Clears Biospace med's Revolutionary Low Dose Xray Imager 2FDA Clears Biospace med's Revolutionary Low Dose Xray Imager 3FDA Clears Biospace med's Revolutionary Low Dose Xray Imager 4Genstruct's Andrea Matthews Selected for Mass High Tech's 'People to Watch Under 30' 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 3
(Date:11/25/2009)...heart pumps some 250 million liters of blood throu...ibers of the heart have to be extremely durable. T..., vice chair of the Department of Medicine III at .... H. A. Katus), has discovered a protein that is r...lar unit, the sarcomere. In cooperation with other...
(Date:11/24/2009)...prescribed by traditional healers in Brazil to tre...pain to fever and flu. , Now for the first time, ... to scientifically prove the pain relieving proper...lian mint. , Testing this ancient South American ...Rocha was able to show that when prepared as a ,te...
(Date:11/24/2009)...ein that may help gut bacteria bind to the gastroi...iotic producers to identify strains that are likel...need to interact with cells lining the gut to have...es in the gut they are more likely to stick around...halie Juge from the Institute of Food Research. I...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Got a pain? -- Have a cup of Brazilian mint 2A sticky solution for identifying effective probiotics 2Data Published in The New England Journal of Medicine Support Use of Raxibacumab 28ABthrax 28TM 29 29 for the Treatment of Inhalation Anthrax 12949 1Data Published in The New England Journal of Medicine Support Use of Raxibacumab 28ABthrax 28TM 29 29 for the Treatment of Inhalation Anthrax 12949 2Data Published in The New England Journal of Medicine Support Use of Raxibacumab 28ABthrax 28TM 29 29 for the Treatment of Inhalation Anthrax 12949 3Data Published in The New England Journal of Medicine Support Use of Raxibacumab 28ABthrax 28TM 29 29 for the Treatment of Inhalation Anthrax 12949 4Data Published in The New England Journal of Medicine Support Use of Raxibacumab 28ABthrax 28TM 29 29 for the Treatment of Inhalation Anthrax 12949 5Go Healthy Announces Negotiations With Bottling Facilities 51183 1Go Healthy Announces Negotiations With Bottling Facilities 51183 2Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast 12948 1Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast 12948 2
...ditions to come , Human-induced climate change i...titudes. To assess whether the onset of drier con...wly developed multicentury tree ring records from ...on drought in northwestern Africa. Using a new set...ntica) and Aleppo pines ( Pinus halepensis ), the ...
...ellow. Do you gun the engine and speed through the...their green, or do you slow down and wait your tur...lity, according to new research from Tel Aviv Univ...he Department of Zoology at Tel Aviv University, r...le adopt risk-taking behaviors similar to those of...
...stigating exactly how chemotherapy drugs kill canc...test the effectiveness of safer new agents. , Dr S...y of Manchester,s Faculty of Life Sciences have ta...otic drugs, which are used extensively for breast ...s, which includes the agent taxol, has been used c...
Other Biology News:AGU journal highlights -- August 6, 2008 2AGU journal highlights -- August 6, 2008 3AGU journal highlights -- August 6, 2008 4AGU journal highlights -- August 6, 2008 5AGU journal highlights -- August 6, 2008 6AGU journal highlights -- August 6, 2008 7Humans' response to risk can be unnecessarily dangerous, finds Tel Aviv University study 2How chemo kills tumors: research to reduce side effects 2How chemo kills tumors: research to reduce side effects 3
10% BSA in TBS from Upstate
Rabbit Anti-Aortic Elastin Polyclonal Antibody, Unconjugated from Abcam
Anti-Mouse VEGF-C Antibody, Unconjugated from Raybiotech, Inc.
Rabbit Anti-MEF2A, phospho (Thr312) Antibody, Unconjugated from Spring Bioscience
Biology Products: